Status:
COMPLETED
Paleolithic Diet in the Treatment of Diabetes Type 2 in Primary Health Care
Lead Sponsor:
Lund University Hospital
Conditions:
Diabetes Mellitus, Type 2
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
There is uncertainty about the optimal diet in the prevention and treatment of diabetes type 2. Earlier studies have generally focused on intakes of fat, protein, carbohydrate, fiber, fruit and vegeta...
Eligibility Criteria
Inclusion
- Adults with capacity to perform study
- Diabetes Mellitus Type 2
- C-peptide \> 0
- HbA1C \>5.5
- Unchanged diabetes treatment during last 3 months
- Weight and HbA1C varied less than 5% during last 3 months
- No acute heart disease during last 6 months
- Unchanged treatment with betablocker last 6 months
- Unchanged treatment with thyroid hormone substitution last 6 months
Exclusion
- Treatment with insulin
- Chronic treatment with steroids (not inhaled)
- Treatment with Waran (anticoagulant cumarin type)
- Creatinin \> 130 micromol/L
- Elevated liver enzymes (ALAT,ASAT,ALP or GT \> 4 X upper reference value)
- Acute heart disease
- Changed treatment with betablocker or thyroid hormone substitution
Key Trial Info
Start Date :
January 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2007
Estimated Enrollment :
13 Patients enrolled
Trial Details
Trial ID
NCT00435240
Start Date
January 1 2005
End Date
September 1 2007
Last Update
May 15 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Lund University Hospital
Lund, Skåne County, Sweden, 22185